Harmony Medical
1
14M
1
0.03
1
- Areas of investment
Summary
In 1985 was created Harmony Medical, which is appeared as Corporate Investor.
The top amount of exits for fund were in 2019. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars.
The usual cause for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Swiss RE, STMicroelectronics, PM Equity Partner.
Among the most popular fund investment industries, there are Diabetes, Cloud Computing. Among the most popular portfolio startups of the fund, we may highlight Biovotion. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.03
- Investments by industry
- Fitness (1)
- Diabetes (1)
- Health Care (1)
- Wearables (1)
- mHealth (1) Show 1 more
- Investments by region
-
- Switzerland (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 1.00
- Avg. company exit year
- 8
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Biovotion | 11 Jul 2017 | Fitness, Health Care, Cloud Computing, mHealth, Wearables, Diabetes | Early Stage Venture | 14M | Switzerland, Zurich |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.